Form D Explorer

Source evidence

CND Life Sciences, Inc. · 0001841099-26-000001

D filed June 16, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
SCOTTSDALE
street1
9165 E. DEL CAMINO DRIVE
street2
SUITE 101
zipCode
85258-4381
entityName
CND Life Sciences, Inc.
entityType
Corporation
stateOrCountry
AZ
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold4314750number4314750/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount6250000number6250000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment25000number25000/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 10e1fde55366fefaf22afdf2a3a23f9f7026804d5e50d8630975a46ec31f0d4e. This proves extraction identity, not the accuracy of the filer's claims.